HomeClinical TopicsFDA approves first generic version of Nexium

FDA approves first generic version of Nexium

On January 26, the U.S. Food and Drug Administration (FDA) approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content